These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 36266933)
1. Delineation of biomarkers and molecular pathways of residual effects of fluoxetine treatment in juvenile rhesus monkeys by proteomic profiling. Yan Y; Park DI; Horn A; Golub M; Turck CW Zool Res; 2023 Jan; 44(1):30-42. PubMed ID: 36266933 [TBL] [Abstract][Full Text] [Related]
2. Serotonin Transporter Binding Potentials in Brain of Juvenile Monkeys 1 Year After Discontinuation of a 2-Year Treatment With Fluoxetine. Golub MS; Hogrefe CE; Campos LJ; Fox AS Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Nov; 4(11):948-955. PubMed ID: 31471184 [TBL] [Abstract][Full Text] [Related]
3. Identifying individual differences of fluoxetine response in juvenile rhesus monkeys by metabolite profiling. He Y; Hogrefe CE; Grapov D; Palazoglu M; Fiehn O; Turck CW; Golub MS Transl Psychiatry; 2014 Nov; 4(11):e478. PubMed ID: 25369145 [TBL] [Abstract][Full Text] [Related]
8. Peer social interaction is facilitated in juvenile rhesus monkeys treated with fluoxetine. Golub MS; Hogrefe CE; Bulleri AM Neuropharmacology; 2016 Jun; 105():553-560. PubMed ID: 26905291 [TBL] [Abstract][Full Text] [Related]
9. Regulation of emotional response in juvenile monkeys treated with fluoxetine: MAOA interactions. Golub MS; Hogrefe CE; Bulleri AM Eur Neuropsychopharmacol; 2016 Dec; 26(12):1920-1929. PubMed ID: 27852517 [TBL] [Abstract][Full Text] [Related]
10. 5-HTTLPR genotype and gender, but not chronic fluoxetine administration, are associated with cortical TREK1 protein expression in rhesus macaques. Bogdan R; Fitzgibbon H; Woolverton WL; Bethea CL; Iyo AH; Stockmeier CA; Kyle PB; Austin MC Neurosci Lett; 2011 Oct; 503(2):83-6. PubMed ID: 21871532 [TBL] [Abstract][Full Text] [Related]
11. Bone growth in juvenile rhesus monkeys is influenced by 5HTTLPR polymorphisms and interactions between 5HTTLPR polymorphisms and fluoxetine. Golub MS; Bulleri AM; Hogrefe CE; Sherwood RJ Bone; 2015 Oct; 79():162-9. PubMed ID: 26067181 [TBL] [Abstract][Full Text] [Related]
12. Fluoxetine: juvenile pharmacokinetics in a nonhuman primate model. Golub MS; Hogrefe CE Psychopharmacology (Berl); 2014 Oct; 231(20):4041-7. PubMed ID: 24700388 [TBL] [Abstract][Full Text] [Related]
13. Neurobiological changes mediating the effects of chronic fluoxetine on cocaine use. Sawyer EK; Mun J; Nye JA; Kimmel HL; Voll RJ; Stehouwer JS; Rice KC; Goodman MM; Howell LL Neuropsychopharmacology; 2012 Jul; 37(8):1816-24. PubMed ID: 22434223 [TBL] [Abstract][Full Text] [Related]
14. Sleep disturbance as detected by actigraphy in pre-pubertal juvenile monkeys receiving therapeutic doses of fluoxetine. Golub MS; Hogrefe CE Neurotoxicol Teratol; 2016; 55():1-7. PubMed ID: 26956991 [TBL] [Abstract][Full Text] [Related]
15. Other Antidepressants. Schwasinger-Schmidt TE; Macaluso M Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544 [TBL] [Abstract][Full Text] [Related]
16. Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life. Wegerer V; Moll GH; Bagli M; Rothenberger A; Rüther E; Huether G J Child Adolesc Psychopharmacol; 1999; 9(1):13-24; discussion 25-6. PubMed ID: 10357514 [TBL] [Abstract][Full Text] [Related]
17. Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat. Johansson D; Falk A; Marcus MM; Svensson TH Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):143-8. PubMed ID: 22691715 [TBL] [Abstract][Full Text] [Related]
18. Disorder-dissociated effects of fluoxetine on brain function of working memory in attention deficit hyperactivity disorder and autism spectrum disorder. Chantiluke K; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K Psychol Med; 2015 Apr; 45(6):1195-205. PubMed ID: 25292351 [TBL] [Abstract][Full Text] [Related]
19. Sex-Based Impact of Creatine Supplementation on Depressive Symptoms, Brain Serotonin and SSRI Efficacy in an Animal Model of Treatment-Resistant Depression. Kanekar S; Ettaro R; Hoffman MD; Ombach HJ; Brown J; Lynch C; Sheth CS; Renshaw PF Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360959 [TBL] [Abstract][Full Text] [Related]
20. RU 486 blocks and fluoxetine augments progesterone-induced prolactin secretion in monkeys. Pecins-Thompson M; Bethea CL Neuroendocrinology; 1997 May; 65(5):335-43. PubMed ID: 9158065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]